In contrast, this hyperinflammatory environment is lacking in some tumors where LSECs have been shown to take up tumor-derived cell fragments and soluble antigens, which results in CD8+ tolerance toward tumor cells [62,63]. The gene discussed is CD8A; the disease is neoplasm.